https://www.zonebourse.com/cours/action/VACCINEXPAR-45256990/actualite/Vaccinex-rapporte-un-effet-positif-du-traitement-au-pepinemab-sur-un-nouveau-biomarqueur-de-l-inflam-45179261/?utm_source=telegram&utm_medium=social&utm_campaign=share